Larimar Therapeutics Reports Second Quarter 2025 Financial Results

Go back to Larimar Therapeutics Reports Second Quarter 2025 Financial Results
(NASDAQ: LRMR) Delayed: 4.06 --0 (-0%)
Previous Close $4.06    52 Week High
Open $4.06    52 Week Low
Day High $4.06    P/E N/A 
Day Low $4.06    EPS
Volume 575